Heranova Lifesciences is a biotech company solely focused on developing integrated care solutions for Women's Health. Their goal is to address unmet needs in women's healthcare by offering internally developed and externally partnered diagnostics, drugs, and devices. The company was founded in 2022 by a team of serial entrepreneurs and seasoned MNC executives with support from a world-class Scientific Advisory Board. Heranova has already established presences in the United States and Asia.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/28/23 | $13,500,000 | Seed and Seed+ |
Emerging Technologies Partners Pivotal bioVenture Partners Sinovation Ventures Triwise Capital | undisclosed |
